JW Life Science

Seoul, South Korea Founded: 1994 • Age: 32 yrs Listed
Intravenous solutions and pharmaceuticals are manufactured for healthcare providers.

About JW Life Science

JW Life Science is a publicly listed company based in Seoul (South Korea) founded in 1994. Intravenous solutions and pharmaceuticals are manufactured for healthcare providers. The company has 328 employees. JW Life Science offers products and services including Intravenous Fluids and Research Services. Its focus areas include Medical Supplies and Consumables and Diversified. Its legal entity is JW생λͺ…κ³Όν•™.

Company details

JW Life Science was founded in 1994 in Seoul, South Korea. Intravenous solutions and a range of pharmaceutical products are manufactured by the company. Research and development activities in related pharmaceutical areas are conducted. Products are supplied to healthcare providers within the medical sector. Operations encompass production, research, and distribution across the pharmaceutical industry.

Key Metrics
  • Annual Revenue
    $178.53 M (USD)
    15.89
    as on Dec 31, 2025
  • Net Profit
    $19.81 M (USD)
    -34.97
    as on Dec 31, 2025
  • EBITDA
    $35.6 M (USD)
    -0.31
    as on Dec 31, 2025
  • Employee Count
    328

Products & Services of JW Life Science

JW Life Science offers a comprehensive portfolio of products and services, including Intravenous Fluids and Research Services.

Intravenous Fluids
Pharmaceutical Products

Intravenous solutions are produced for medical use in hospitals and healthcare settings

Research Services
R&D Services

Research in life sciences and pharmaceuticals is conducted to support product development and innovation

IPO & Listings of JW Life Science

JW Life Science is a publicly listed company on the KRX with ticker symbol 234080 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date27 Oct 2016
  • Listed onKRX: 234080
  • Listed entityJW LIFESCIENCE CORPORATION
  • Exchange sectorHealth technology
  • ISINKR7234080000
  • Share price10,670.00 KRW (-0.28% on the day) · 2026-10-14
  • Market capitalisation165,684,720,707.00 KRW
  • Price to earnings6.3
  • EPS (diluted, trailing year)1,680.36 KRW
  • Dividend yield5.14%
  • Volume (last session)18,729

Financials of JW Life Science

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025257.83B KRW28.61B KRW51.41B KRW
2024222.48B KRW43.99B KRW51.57B KRW
2023206.86B KRW28.14B KRW46.37B KRW
2022188.93B KRW14.96B KRW42.02B KRW
2021169.82B KRW12.91B KRW41.64B KRW
Premium access

Detailed financial statements for JW Life Science

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of JW Life Science

The website of JW Life Science (jw-lifescience.co.kr) receives about 5K visits a month.

  • Monthly visits
    5K
Similar websites

Websites whose visitors overlap most with JW Life Science. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
metamedic.co.kr
metamedic.co.kr
100%
#683,789–
medipana.com
medipana.com
89%
#266,587–
jw-pharma.co.kr
78%
83.5K#347,046View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jw Life Science

Premium access

Complete news archive for JW Life Science

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JW Life Science

JW Life Science was founded in 1994.

JW Life Science is headquartered in Seoul, South Korea.

JW Life Science has 328 employees.

Annual revenue of JW Life Science is $178.53M as on Dec 31, 2025.

JW Life Science was founded in 1994 in Seoul, South Korea. Intravenous solutions and a range of pharmaceutical products are manufactured by the company. Research and development activities in related pharmaceutical areas are conducted. Products are supplied to healthcare providers within the medical sector. Operations encompass production, research, and distribution across the pharmaceutical industry.

JW Life Science offers Intravenous Fluids and Research Services.

Yes, JW Life Science is publicly traded on KRX under the ticker symbol 234080.

JW Life Science operates through Jw생λͺ…κ³Όν•™.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available